Low TTP/HuR mRNA ratios are associated with poor survival in breast cancer patients and high levels of mitotic ARE-mRNA signatures, highlighting the role of AREs and their binding proteins in cancer [49]. The gene discussed is ELAVL1; the disease is breast carcinoma.